Clover Biopharmaceuticals (HKSE:02197) Other Long Term Assets : HK$-0.00 Mil (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Clover Biopharmaceuticals Other Long Term Assets?

Clover Biopharmaceuticals's other long-term assets for the quarter that ended in Jun. 2024 was HK$-0.00 Mil.

Clover Biopharmaceuticals's quarterly other long-term assets declined from Jun. 2023 (HK$19.97 Mil) to Dec. 2023 (HK$-0.00 Mil) but then stayed the same from Dec. 2023 (HK$-0.00 Mil) to Jun. 2024 (HK$-0.00 Mil).

Clover Biopharmaceuticals's annual other long-term assets declined from Dec. 2021 (HK$40.33 Mil) to Dec. 2022 (HK$31.31 Mil) and declined from Dec. 2022 (HK$31.31 Mil) to Dec. 2023 (HK$-0.00 Mil).

Clover Biopharmaceuticals Other Long Term Assets Historical Data

The historical data trend for Clover Biopharmaceuticals's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clover Biopharmaceuticals Other Long Term Assets Chart

Clover Biopharmaceuticals Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

4.62

61.45

40.33

31.31

Clover Biopharmaceuticals Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Other Long Term Assets	Get a 7-Day Free Trial				56.17	31.31	19.97	-	-

Clover Biopharmaceuticals Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Clover Biopharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clover Biopharmaceuticals Ltd (HKSE:02197) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 758 West Nanjing Road, Room 1901, Jing’an District, Shanghai, CHN

Website

https://www.cloverbiopharma.com

Clover Biopharmaceuticals Ltd is a clinical-stage biotechnology company committed to developing novel vaccines and biologic therapeutic candidates for infectious diseases as well as cancer and autoimmune diseases.

Executives

Liang Peng	2101 Beneficial owner
Liang Joshua G	2501 Other
Jpmorgan Chase & Co.	2201 Interest of corporation controlled by you
Hillhouse Investment Management, Ltd.	2102 Investment manager
Aut-xxi Investment Holdings Limited	2201 Interest of corporation controlled by you
Jnry V Holdings Limited	2101 Beneficial owner
Aut-xxi Hk Holdings Limited	2101 Beneficial owner
Aut-xxi Holdings Limited	2201 Interest of corporation controlled by you
Hh Imv Holdings, L.p.	2201 Interest of corporation controlled by you
Hillhouse Fund Iv, L.p.	2201 Interest of corporation controlled by you
Temasek Holdings (private) Limited	2201 Interest of corporation controlled by you
The Core Trust Company Limited	2301 Trustee
Tct (bvi) Limited	2501 Other
Super Novel International Limited	2306 Nominee for another person
Shang Hai Tian He Sheng Tai Qi Ye Guan Li He Huo Qi Ye You Xian He Huo

Clover Biopharmaceuticals Headlines

No Headlines